rimantadine has been researched along with Parkinson Disease in 2 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report our experience with 7 consecutive patients with Parkinson's disease (PD) who received rimantadine (the alpha-methyl derivative of amantadine) in substitution of amantadine due to peripheral side effects (lower limb edema, livedo reticularis)." | 5.11 | Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series. ( Gonzalez, MA; Lieberman, A; Papapetropoulos, S; Roberts, EL; Singer, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duque, MD | 1 |
| Camps, P | 1 |
| Torres, E | 1 |
| Valverde, E | 1 |
| Sureda, FX | 1 |
| López-Querol, M | 1 |
| Camins, A | 1 |
| Prathalingam, SR | 1 |
| Kelly, JM | 1 |
| Vázquez, S | 1 |
| Singer, C | 1 |
| Papapetropoulos, S | 1 |
| Gonzalez, MA | 1 |
| Roberts, EL | 1 |
| Lieberman, A | 1 |
1 trial available for rimantadine and Parkinson Disease
| Article | Year |
|---|---|
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
Topics: Aged; Amantadine; Antiparkinson Agents; Edema; Female; Humans; Middle Aged; Motor Activity; Parkinso | 2005 |
1 other study available for rimantadine and Parkinson Disease
| Article | Year |
|---|---|
New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities.
Topics: Amines; Animals; Antiparkinson Agents; Cells, Cultured; Humans; Memantine; Molecular Structure; Neur | 2010 |